Kidney health Clinical Trials: Active Studies by Market and Country

Clinical studies that are recruiting or active now, for each of our markets on this topic.

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

Active trials by market

Studies that are recruiting, active, or about to start. One study can count for more than one market, so the numbers are not added up.

  1. 1Chronic Kidney Disease1,071Chronic Kidney Disease: See them on ClinicalTrials.gov (opens in a new tab)
  2. 2Chronic Kidney Disease Drugs1,071Chronic Kidney Disease Drugs: See them on ClinicalTrials.gov (opens in a new tab)
  3. 3Benign Prostatic Hyperplasia Treatment202Benign Prostatic Hyperplasia Treatment: See them on ClinicalTrials.gov (opens in a new tab)
  4. 4Overactive Bladder Treatment125Overactive Bladder Treatment: See them on ClinicalTrials.gov (opens in a new tab)
  5. 5Erectile Dysfunction Treatment118Erectile Dysfunction Treatment: See them on ClinicalTrials.gov (opens in a new tab)
  6. 6IgA Nephropathy Treatment117IgA Nephropathy Treatment: See them on ClinicalTrials.gov (opens in a new tab)
  7. 7Testosterone Replacement Therapy70Testosterone Replacement Therapy: See them on ClinicalTrials.gov (opens in a new tab)
  8. 8Kidney Dialysis Access64Kidney Dialysis Access: See them on ClinicalTrials.gov (opens in a new tab)
  9. 9Hyperuricemia Drugs49Hyperuricemia Drugs: See them on ClinicalTrials.gov (opens in a new tab)
  10. 10Chronic Kidney Disease of Unknown Cause1Chronic Kidney Disease of Unknown Cause: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

Recently updated trials

Each opens its own record on ClinicalTrials.gov.

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

Benchmarks on kidney health

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.